Form 4: Cabaletta Bio CEO Boosts Stake with 45,000 Share Purchase

Cabaletta Bio's President and CEO, Steven Nichtberger, acquired 45,000 shares of common stock at a weighted average price of $2.2395, signaling increased insider confidence.

Summary

• Steven Nichtberger, President and CEO of Cabaletta Bio, Inc. (CABA), purchased 45,000 shares of common stock.
• The transaction occurred on January 21, 2026.
• The shares were acquired at a weighted average price of $2.2395, with prices ranging from $2.1985 to $2.26.
• Following this transaction, Steven Nichtberger directly beneficially owns 1,031,483 shares of common stock.
• Additionally, 363,000 shares are indirectly owned by the 2017 Nichtberger Family Trust, though beneficial ownership is disclaimed by the reporting person.

Sentiment

Score: 8

Explanation: The significant purchase of company stock by the President and CEO indicates strong insider confidence and a belief in the company's future prospects, which is a positive signal for investors.

Positives

• A significant purchase of 45,000 shares by the President and CEO indicates strong confidence in the company's future prospects.
• Insider buying often signals that management believes the stock is undervalued.

Negatives

• No explicit negatives are reported in this Form 4 filing.

Risks

• This filing does not contain information regarding company-specific risks.

Future Outlook

This filing does not provide explicit forward-looking statements or guidance, but the insider purchase implicitly suggests a positive outlook from management.

Management Comments

• The reporting person has provided to the Issuer, and undertakes to provide any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Industry Context

Insider buying, particularly by a CEO, is generally viewed positively across all industries as it signals management's belief in the company's intrinsic value and future performance, potentially outperforming peers.

Comparison to Industry Standards

• Not applicable, as this filing reports an individual insider transaction rather than company performance metrics that can be benchmarked against industry standards or specific competitors.

Related Party Transactions

• 363,000 shares are indirectly owned by the 2017 Nichtberger Family Trust, which is a related party to Steven Nichtberger, though beneficial ownership is disclaimed.

Stakeholder Impact

• Shareholders: May view the CEO's purchase as a strong vote of confidence, potentially increasing investor sentiment and demand for the stock.
• Employees: Could interpret the CEO's investment as a positive sign regarding the company's stability and future growth.

Next Steps

• No specific future actions or milestones are mentioned in this insider transaction report.

Key Dates

Recommendation

The President and CEO's substantial purchase of 45,000 shares at market prices is a powerful signal of confidence in Cabaletta Bio's valuation and future prospects. Insider buying, especially from top executives, often precedes positive company developments and suggests the stock is currently undervalued, making it a compelling 'strong buy' opportunity for investors.

Keywords

Cabaletta Bio, CABA, Steven Nichtberger, insider trading, stock purchase, CEO, director, common stock, beneficial ownership